Our commitment to quality: batch by batch
Avextra offers high-quality cannabis-based medicines. Our strength lies within our cultivation in Portugal and the combination of traditional and high-tech extraction methods in Germany. Discover more insights from our CMO David Reckeweg-Lecompte by watching this video.
A selection of other videos
Compiled from the various subject areas.
We at Avextra have had an exciting and successful year! In 2024, we achieved many important milestones. As we look ahead to the next chapter of our journey in 2025, here is look back at some of our key highlights from 2024.
Reflecting on a remarkable and successful year at Avextra. We’re ready for another year of achievements in 2024.
Avextra combines decades of experience in plant-based pharmaceutical production with innovative manufacturing processes. Our experts harness the therapeutic potential of the cannabis plant to improve patients' quality of life.
Avextra offers high-quality cannabis-based medicines. Our strength lies within our cultivation in Portugal and the combination of traditional and high-tech extraction methods in Germany. Discover more insights from our CMO David Reckeweg-Lecompte by watching this video.
At Avextra, we focus on research and development of cannabis medicine to create innovative dosage forms and drive evidence-based research. Learn more with this video.
Hear from Avextra’s experts how we are setting new standards in cannabis medicine and realizing the full potential of the plant in this video clip.
Check out our state-of-the-art medical cannabis cultivation facility in Portugal in this behind-the-scenes tour!
Our 2022 highlight video gives a sneak peek at some of the exciting things we've been working on and hints at what's to come.
Europe’s leader in Cannabis-based medicine
Das komplette Interview zu möglichen Vorteilen der Therapie mit medizinischem Cannabis finden Sie im Media Center für Fachkreise.
Das komplette Interview über den Einsatz von Cannabis-Medizin in der Palliativmedizin finden Sie im Media Center für Fachkreise.
Das komplette Interview zum möglichen Einsatz von Cannabis-Medizin in der Kinderpalliativversorgung finden Sie im Media Center für Fachkreise.
Podcasts

Neil Smith featured on Planted with Sara Payan.
Sara discusses the European cannabis landscape and new movement in R&D with Neil Smith, COO of German bio-pharmaceutical company Avextra.
Press Releases
Please find the latest press releases from Avextra here.
Schottischer Ex-Banker leitet Firma, die auf Cannabisprodukte zur Behandlung chronischer Schmerzen spezialisiert ist
Neil Smith, 56, ist der Vorsitzende des in Deutschland ansässigen Unternehmens Eurox Pharma und CEO der Integro Medical Clinic, die Medikamente an Menschen im Vereinigten…
Cannabisextrakte Made in Germany
Beim hiesigen Angebot für medizinisches Cannabis ist man auf Anbieterseite vor allem die Namen gewohnt, die man auch vom Blick über den Atlantik kennt. Eurox…
Staatssekretär Dr. Michael Meister besichtigt die Eurox Pharma Produktionsanlage
Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Die Unternehmen haben es sich zum Ziel gesetzt, das erste Inhalationsdevice zur Verabreichung von standardisierten Cannabisextrakten…
Eurox bringt die ersten Cannabis-Derivate “Made in Germany” auf den heimischen Markt
Die ersten selbst hergestellten medizinischen Cannabisprodukte werden in wenigen Wochen auf dem deutschen Markt eingeführt. Dies geschieht, nachdem die Eurox Group – der Hersteller der…
Das Potential der Cannabismedizin
Die Cannabismedizin bietet besonderes Potential, um die Versorgung der Patientinnen und Patienten in Deutschland zu verbessern. Darin waren sich die Bundestagsabgeordnete von Bündnis 90/Die Grünen,…
Neue Investition – Europäisches Unternehmen für medizinischen Cannabis
Fast Forward Innovations Ltd. freut sich bekannt zu geben, dass es 3 Millionen Euro in die Eurox Group investiert hat.
Eurox Pharma-Führungsteam nimmt als Hauptredner an der Cannabis Business Europe teil
Eurox Pharma, eines der führenden europäischen Unternehmen für medizinisches Cannabis, freut sich bekannt zu geben, dass es eingeladen wurde, auf der Cannabis Business Europe 2021…
Zusammenarbeiten, um medizinisches Cannabis als Medizin in Europa zugänglicher zu machen
Heute teilen Dr. Bernhard Babel und Neil Smith bei CBD Live ihr Wissen und ihre Ansichten darüber, wie Cannabis-basierte Medikamente in Europa besser zugänglich gemacht…
State Secretary Dr. Michael Meister visits the Eurox Pharma production plant
During the appointment, which lasted just under two hours, the two Eurox managing directors David Reckeweg-Lecompte and Dr. Bernhard Babel explained the special role of…
Eurox To Launch First ‘Made In Germany’ Cannabis Derivatives Into The Domestic Market
THE first home-made medical cannabis products will debut on the German market within weeks. This comes as Eurox Group – the producer of the derivatives range –…
Potential of cannabis medicine
Cannabis medicine offers particular potential to improve patient care in Germany. The member of the Bundestag of Bündnis 90/Die Grünen, Daniela Wagner, and the two…
New investment – European medical cannabis company
FastForward Innovations Ltd, is pleased to announce that it has invested €3 million in Eurox Group.
Eurox Pharma Leadership Team to Participate as Keynote Speaker at Cannabis
Eurox Pharma is pleased to announce that it has been invited to speak at the Cannabis Business Europe 2021 in Frankfurt, Germany.
Working together to make medical cannabis more accessible as a medicine in Europe
Today Dr. Bernhard Babel and Neil Smith share their knowledge and views on how to make Cannabis-based Medicines more accessible in Europe at CBD Live.…
Eurox Pharma To Deliver The First ‘Made in Germany’ THC Oils Into The Domestic Market
AMBITIOUS medical cannabis company Eurox Pharma is just weeks away from launching the first domestically-produced THC oils into the German market.
Eurox Pharma are delighted to announce the addition of cannabis industry heavy-weight Chuck Rifici to their Board
Rifici is currently Executive Chairman of Feather Company and co-founder of Canopy Growth Corporation and the Auxly Cannabis Group. He previously served on the board…
PRESS CONTaCT
